These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34986854)

  • 41. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status and perspectives of regulatory T cell-based therapy.
    Qu G; Chen J; Li Y; Yuan Y; Liang R; Li B
    J Genet Genomics; 2022 Jul; 49(7):599-611. PubMed ID: 35636740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner.
    Janssens I; Campillo Davó D; Van den Bos J; De Reu H; Berneman ZN; Wens I; Cools N
    Cytotherapy; 2022 Jun; 24(6):659-672. PubMed ID: 35193826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans.
    Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.
    Seay HR; Putnam AL; Cserny J; Posgai AL; Rosenau EH; Wingard JR; Girard KF; Kraus M; Lares AP; Brown HL; Brown KS; Balavage KT; Peters LD; Bushdorf AN; Atkinson MA; Bluestone JA; Haller MJ; Brusko TM
    Mol Ther Methods Clin Dev; 2017 Mar; 4():178-191. PubMed ID: 28345003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications.
    Golab K; Leveson-Gower D; Wang XJ; Grzanka J; Marek-Trzonkowska N; Krzystyniak A; Millis JM; Trzonkowski P; Witkowski P
    Int Immunopharmacol; 2013 Jul; 16(3):371-5. PubMed ID: 23428908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
    Nishikii H; Kim BS; Yokoyama Y; Chen Y; Baker J; Pierini A; Alvarez M; Mavers M; Maas-Bauer K; Pan Y; Chiba S; Negrin RS
    Blood; 2016 Dec; 128(24):2846-2858. PubMed ID: 27760760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor reactive regulatory T cells.
    Feng G; Chan T; Wood KJ; Bushell A
    Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation.
    Orozco G; Gupta M; Gedaly R; Marti F
    Front Immunol; 2022; 13():883855. PubMed ID: 35720387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory T-cell therapy in transplantation: moving to the clinic.
    Tang Q; Bluestone JA
    Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.
    Esensten JH; Muller YD; Bluestone JA; Tang Q
    J Allergy Clin Immunol; 2018 Dec; 142(6):1710-1718. PubMed ID: 30367909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Good Manufacturing Practice-compliant change of raw material in the manufacturing process of a clinically used advanced therapy medicinal product-a comparability study.
    Wixmerten A; Miot S; Bittorf P; Wolf F; Feliciano S; Hackenberg S; Häusner S; Krenger W; Haug M; Martin I; Pullig O; Barbero A
    Cytotherapy; 2023 May; 25(5):548-558. PubMed ID: 36894437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Media fill for validation of a good manufacturing practice-compliant cell production process.
    Serra M; Roseti L; Bassi A
    Methods Mol Biol; 2015; 1283():161-9. PubMed ID: 25096172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
    Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
    Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.
    He X; Landman S; Bauland SC; van den Dolder J; Koenen HJ; Joosten I
    PLoS One; 2016; 11(5):e0156311. PubMed ID: 27224512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased Foxp3
    Chen YB; Efebera YA; Johnston L; Ball ED; Avigan D; Lekakis LJ; Bachier CR; Martin P; Duramad O; Ishii Y; Han S; Jung YJ; Lee D; Kunkel L; Negrin RS; Bui JD
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):625-634. PubMed ID: 28104514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing.
    Korbutt GS
    Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methods to manufacture regulatory T cells for cell therapy.
    MacDonald KN; Piret JM; Levings MK
    Clin Exp Immunol; 2019 Jul; 197(1):52-63. PubMed ID: 30913302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.